Back to User profile » Professor Yi-Ping Fang
Papers published by Professor Yi-Ping Fang:
Transmucosal Delivery of miR-30c-5p by Chitosan Nanoparticles for Oral Squamous Cell Carcinoma
Fang YP, Lin YC, Lin CY, Wang PJ, Chang TY, Hsieh YJ
International Journal of Nanomedicine 2025, 20:9179-9194
Published Date: 19 July 2025
Improving the Thrombocytopenia Adverse Reaction of Belinostat Using Human Serum Albumin Nanoparticles
Liu JY, Yen CH, Lin YF, Feng YH, Fang YP
International Journal of Nanomedicine 2024, 19:10785-10800
Published Date: 25 October 2024
Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis
Chou PL, Huang YP, Cheng MH, Rau KM, Fang YP
International Journal of Nanomedicine 2020, 15:1731-1743
Published Date: 12 March 2020
SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
Fang YP, Chuang CH, Wu YJ, Lin HC, Lu YC
International Journal of Nanomedicine 2018, 13:2789-2802
Published Date: 10 May 2018
Diminishing the side effect of mitomycin C by using pH-sensitive liposomes: in vitro characterization and in vivo pharmacokinetics
Fang YP, Hu PY, Huang YB
Drug Design, Development and Therapy 2018, 12:159-169
Published Date: 15 January 2018
Amsacrine analog-loaded solid lipid nanoparticle to resolve insolubility for injection delivery: characterization and pharmacokinetics
Fang YP, Chuang CH, Wu PC, Huang YB, Tzeng CC, Chen YL, Liu YT, Tsai YH, Tsai MJ
Drug Design, Development and Therapy 2016, 10:1019-1028
Published Date: 4 March 2016
Mesoporous silica nanoparticles synthesized from liquid crystal display manufacturing extracts as a potential candidate for a drug delivery carrier: evaluation of their safety and biocompatibility
Lin YC, Lin LY, Gao MY, Fang YP
International Journal of Nanomedicine 2013, 8:3833-3842
Published Date: 11 October 2013
Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery
Fang YP, Wu PC, Huang YB, Tzeng CC, Chen YL, Hung YH, Tsai MJ, Tsai YH
International Journal of Nanomedicine 2012, 7:4995-5005
Published Date: 17 September 2012
Topical delivery of DNA oligonucleotide to induce p53 generation in the skin via thymidine dinucleotide (pTT)-encapsulated liposomal carrier
Fang YP
International Journal of Nanomedicine 2011, 6:3373-3381
Published Date: 20 December 2011